Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 59Gastrointestinal Stromal Tumors 22Neoplasms 18Breast Neoplasms 16Kidney Neoplasms 12Carcinoma, Non-Small-Cell Lung 11Carcinoma 7Colorectal Neoplasms 6Neoplasm Metastasis 5Stomach Neoplasms 4Neuroendocrine Tumors 4Kidney Diseases 4Gastrointestinal Neoplasms 4Clear-cell metastatic renal cell carcinoma 4Carcinoma, Hepatocellular 4Adenoma, Islet Cell 4Prostatic Neoplasms 3Urologic Neoplasms 2Urogenital Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Financial Stress 2Urothelial Cancer 1Urologic Diseases 1Thyroid Neoplasms 1Somatostatinoma 1Solid Tumors 1Solid Tumor 1Primary hyperoxaluria type 2 1Patient Preference 1

Interventions

Mitomycin 3vofatamab 2pembrolizumab 2B701 protein, Human herpesvirus 6 2valrubicin 1trifluridine tipiracil drug combination 1palbociclib 1enfortumab vedotin 1atezolizumab 1Water 1Sunitinib 1Standard of Care 1Radiation Dose Hypofractionation 1Gemcitabine 1Gels 1Fluorouracil 1Docetaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Urologic Diseases × Sunitinib × Clear all
NCT02386111 2018-07-26

A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma

Celldex Therapeutics

Phase 1 Terminated
17 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms, Neoplasms by Histologic Type, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡